Exploring the Efficacy of Assistive Artificial Intelligence for Ultrasound Guided Regional Anesthesia in Residency Training

February 27, 2026 updated by: Christopher Fadumiye, Medical College of Wisconsin
The purpose of this study is to investigate the efficacy of a novel artificial intelligence (AI) device designed to assist in Ultrasound guided regional anesthesia (ScanNav Anatomy Peripheral Nerve Block; ScanNav), in the teaching and training of anesthesiology residents in the subspecialty of regional anesthesia.

Study Overview

Detailed Description

Ultrasound-guided regional anesthesia (UGRA) relies on the precise acquisition and interpretation of ultrasound images. The necessary skills to attain this is dependent on the knowledge of the underlying anatomy. Notwithstanding, even experienced anesthesiologists can find this challenging, especially in the setting of anatomical variation, obesity and other potential confounders. This study aims to clarify if The ScanNav, a novel artificial intelligence device designed to assist in UGRA, when utilized with trainees, improves their uptake and training. We also aim to see the relationships of how it enhances teaching and training of residents by experienced regional anesthesia providers.

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Wisconsin
      • Milwaukee, Wisconsin, United States, 53226
        • Medical College of Wisconsin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The student population includes anesthesia residents in training, and experienced regional anesthesia providers.

Description

Inclusion Criteria:

  • Inclusion criteria include any anesthesia resident with no prior experience with UGRA.

Exclusion Criteria:

  • Exclusion criteria include any anesthesia resident who has undergone the regional elective service prior to the inception of the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
The study will recruit the entire CA1 resident class (n=20)
The study will recruit the entire CA1-2 resident class (n=20-30) who have no prior experience with Ultrasound guided regional anesthesia (UGRA) at the Medical College of Wisconsin/Froedtert Hospital. Inclusion criteria include having no prior experience with UGRA. Exclusion criteria include having undergone the regional elective service prior to the inception of the study (CA-2/3 class). No intervention of interest is noted, the cohort will be accessed based on use of the artificial intelligent Ultrasound.
The ScanNav, a novel artificial intelligence device designed to assist in Ultrasound guided regional anesthesia.We also aim to see of how it enhances teaching and training of residents by experienced regional anesthesia providers. We intend to use surveys/questionnaires of both resident and regional anesthesia provider as they utilize the device in real time.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Qualtric questionaire of participants
Time Frame: From enrollment to the end of device use at 2 weeks.
Improved teaching and training of anesthesiology residents in the subspecialty of regional anesthesia will be accessed via a questionnaire filled out by participants after use of the device. The questionnaire will access, the type of regional blocks, feasibility of block and ease of teaching with the artificial intelligence Ultrasound.
From enrollment to the end of device use at 2 weeks.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 10, 2025

Primary Completion (Actual)

January 1, 2026

Study Completion (Actual)

January 1, 2026

Study Registration Dates

First Submitted

October 27, 2024

First Submitted That Met QC Criteria

October 29, 2024

First Posted (Actual)

October 31, 2024

Study Record Updates

Last Update Posted (Actual)

March 3, 2026

Last Update Submitted That Met QC Criteria

February 27, 2026

Last Verified

October 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Quantitative data analysed, results, study information and protocol

IPD Sharing Time Frame

When published with ICMJE journal and as requested.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Regional Anesthesia

Subscribe